Operating CompanyGreater Boston
Signablok, Inc.
Operating Company
· Worcester, MA
Signablok develops SCHOOL-technology peptide therapeutics and targeted nanoparticle platforms, including a TREM-1 inhibitor for rheumatoid arthritis.
Founded
Region
Greater Boston
Investors
People